July 7 — Naohu Technology’s implantable brain–computer interface (BCI) hand
motor-function compensation system, described as fully implanted, fully wireless
and full-function, began a GCP registration clinical trial at Fudan
University‑affiliated Huashan Hospital. The multicenter GCP trial will be run
with 15 tertiary hospitals in Shanghai and other regions to evaluate safety and
efficacy for compensating upper‑limb function in patients with tetraplegia from
spinal cord injury. The cervical device is the first subdural cortical‑surface
implantable BCI to enter China’s national Class III medical device registration
clinical stage, marking a key step toward scaled clinical application of BCI
technology in China.
